3652 results for «238»
3652 results
Left main multivessel disease and other coronary interventions
15 Dec 2022 – From GulfPCR-GIM 2022
This GulfPCR-GIM 2022 session will allow you to study a rare case of coronary artery dissection due to blunt chest trauma leading to myocardial infarction, the evolution from LAD to LMS stenting, the use of a mini-crush for a complex left main bifurcation, and much more!
Left main and multivessel disease - Session 1
15 Dec 2022 – From GulfPCR-GIM 2022
Consult this session on left main and multivessel disease to discover a selection of cases presented during Gulf PCR 2022: multiple bifurcation lesions in an octogenarian and high-bleeding risk case, left anterior descending CTO complicated by left main thrombus with left main trifurcation stenting, and much more!
STEMI - Adjunctive pharmacotherapy
15 Dec 2022 – From GulfPCR-GIM 2022
This GulfPCR-GIM 2022 session will enable you to view a case of cardiogenic shock on anterior STEMI, as well as a complicated double-vessel intervention in inferior wall myocardial infarction with cardiogenic shock and acute LVF-PCI-RCA and LMCA-LAD, among others!
The why and how of performing plaque modification in calcified lesions
15 Dec 2022 – From GulfPCR-GIM 2022
Consult this session to learn more about the different kinds of lesions we face during coronary angiography and the different tools and techniques available to treat calcified lesions, as well as to discover how to prepare for each procedure to treat calcified lesion and how to manage complications.
Mitral and other valvular and structural interventions
15 Dec 2022 – From GulfPCR-GIM 2022
Take advantage of this GulfPCR-GIM 2022 session to observe inadvertent pulmonary artery puncture during balloon valvuloplasty in a pregnant patient with severe rheumatic mitral stenosis, device sizing in transcatheter closure of a ruptured sinus of Valsalva aneurysm, and more!
STEMI - Tools, devices and techniques
15 Dec 2022 – From GulfPCR-GIM 2022
Among the 4 GulfPCR-GIM 2022 cases presented in this session, discover a curious case of type 4 dual left anterior descending artery presenting with STEMI, or an inferior wall STEMI with complete heart block in anomalous right coronary artery.
Left main and multivessel disease - Session 2
15 Dec 2022 – From GulfPCR-GIM 2022
View a sudden LM stem occlusion, a LM dissection during CTO, or even a rotablation in LM triple vessel disease in severe left ventricle dysfunction, and much more in this GulfPCR-GIM 2022 session.
Bifurcation lesion - Tools, devices and techniques
15 Dec 2022 – From GulfPCR-GIM 2022
This GulfPCR-GIM 2022 session will get you thinking about how to best plan for severe left main bifurcation and severe calcification/low ejection fraction in non-surgical candidates, and how to manage difficult decisions in left main bifurcation stenting, among others!
Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial
29 Mar 2025
Aaysha Cader provides her take on the ECLIPSE trial presented by Gregg W. Stone at ACC.25 in Chicago.
Author
PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction
03 Apr 2022
Nicola Ryan provides a PICOT analysis of PACMAN AMI: a double-blind, placebo-controlled, randomized trial presented at ACC 2022 and simultaneously published in JAMA.
Author
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
Comparison of a precision care strategy with usual testing to guide management of stable patients with suspected CAD: the PRECISE randomized trial
09 Nov 2022
Alex Sticchi provides his take on PRECISE, which was presented during AHA 2022 in Chicago.
Author
